Vascular aspects of oestrogen.
Collins
P
P
Department of Cardiac Medicine, National Heart and Lung Institute, London, UK.
D002560:Cerebrovascular Circulation / Q000187:drug effects* / Q000502:physiology; D004730:Endothelium, Vascular / Q000187:drug effects; D011464:Epoprostenol / Q000096:biosynthesis / Q000502:physiology; D004958:Estradiol / Q000494:pharmacology / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy / Q000009:adverse effects* / Q000706:statistics & numerical data; D004967:Estrogens / Q000009:adverse effects* / Q000502:physiology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009569:Nitric Oxide / Q000096:biosynthesis / Q000502:physiology; D019001:Nitric Oxide Synthase / Q000096:biosynthesis / Q000502:physiology; D017698:Postmenopause / Q000187:drug effects; D012039:Regional Blood Flow / Q000187:drug effects; D012727:Sex Characteristics; D014599:Uterus / Q000098:blood supply; D014661:Vasoconstriction / Q000187:drug effects
D004967:Estrogens; D009569:Nitric Oxide; D004958:Estradiol; D011464:Epoprostenol; D019001:Nitric Oxide Synthase